TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MERCK & CO. Share Price

Certificat

DE000SF8RCV1

Delayed Deutsche Boerse AG 02:20:22 03/06/2024 pm IST
4.98 EUR +0.61% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MERCK & CO.
1 month-9.51%
3 months-6.78%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
03/24/03 4.98 +0.61%
31/24/31 4.95 +0.20%
30/24/30 4.94 -2.56%
29/24/29 5.07 +0.80%
28/24/28 5.03 -4.73%

Delayed Quote Deutsche Boerse AG

Last update June 03, 2024 at 02:20 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SF8RCV
ISINDE000SF8RCV1
Date issued 04/10/2021
Strike 71.65 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.94
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.74
Lowest since issue 0.82
Spread 0.06
Spread %1.19%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5 USD
Average target price
141.9 USD
Spread / Average Target
+13.01%
Consensus